Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
New therapeutics that antagonize endothelin: promises and frustrations — Giuseppe Remuzzi (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
New therapeutics that antagonize endothelin: promises and frustrations
Shared by
Giuseppe Remuzzi
New therapeutics that antagonize endothelin: promises and frustrations
Article
2002
en
Authors
Giuseppe Remuzzi
NP
Norberto Perico
AB
Ariela Benigni
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Editorial Material
2000
Promises and pitfalls of therapeutics to modify oxidant balance in chronic disease.
George Perry
,
Smith Ma
Article
2013
[Therapeutics. New anticoagulants: stop the controversy!].
David M. Smadja
Article
2012
New developments in Toll-like receptor targeted therapeutics
Dympna J. Connolly
,
Luke O'neill
Current Opinion in Pharmacology
Chapter in a book
2021
Nanomedicine: Promises and challenges
Erha Basit
,
Farwa Batool Shamsi
,
Maryam Zaheer Kiyani
,
Shmaim Ramzan
,
Awais Ahmad
,
Anish Khan
,
Abdullah Mohamed Asiri
Letter
2006
Combining the old with the new to improve therapeutics
Jean Louis Vincent
.webp)
Discussion(0)
No comments yet. Be the first to comment.